Recent Updates
Recently added Catalysts
WAT Positive Sentiment

Waters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs News Summary: Reduces sample volume requirements by 25x through use of advanced microfluidic technologies while increasing throughput up to 24x...

Key Takeaway: Waters Corporation has launched the TA Instruments Rapid Screening-Differential Scanning Calorimeter (RS-DSC), designed for high-throughput thermal stability testing of antibody drugs. This new instrument significantly enhances testing efficiency by allowing up to 24 simultaneous measurements while reducing sample volume needs by 25 times. The RS-DSC aims to meet the increasing demand for faster stability testing in biopharmaceutical development by providing a convenient and precise alternative to current technologies. The product is now available globally through Waters Corporation's TA Instruments Division.
Price reaction · baseline $307.22 (2024-07-22 close) · hit after-hours · clean, no other WAT news in the window
day 0 close · peak
-2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • New TA Instruments RS-DSC allows for 24x faster thermal stability testing.
  • Reduces sample volume requirements by 25x using microfluidic technology.
  • Offers high throughput and more accurate insights for biologic formulations.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~19 mo
Low dilution risk
Lead asset
CYTALUX preoperatively
Phase 2 · Esophageal Cancer

Full Press Release Details

MILFORD, Mass. , July 23, 2024 /PRNewswire/ -- Waters Corporation (NYSE: WAT ) announced today the global release of the TA Instruments™ Rapid Screening-Differential Scanning Calorimeter (TA Instruments RS-DSC), designed for biopharmaceutical developers. The TA Instruments RS-DSC is a high-throughput DSC for precise thermal stability testing of high-concentration biologic formulations specifically for antibody drugs and engineered proteins.
The TA Instruments RS-DSC offers a more convenient and accurate solution to assess biological drug stability and quality
"Demand is increasing for higher concentration injectable drugs, and biologic developers are looking for stability testing that is fast and efficient," said Jianqing Bennett , Waters Corporation Senior Vice President of the TA Instruments Division. "Our new Rapid Screening-DSC meets these needs by providing a high-throughput alternative to existing capillary DSCs and a more reliable and accurate option to differential scanning fluorescence (DSF) technologies."
The TA Instruments RS-DSC offers a more convenient and accurate solution to assess biological drug stability and quality by employing disposable, low sample volume microfluidic chips (MFCs) that enable up to 24 simultaneous measurements. This reduces or eliminates the need for sample dilution, repetitive instrument cleaning, and lowers contamination risk. Its unique design avoids the sensitivity challenges of DSF methods, enabling it to produce more accurate data iii on high-concentration samples.
Additionally, the TA Instruments RS-DSC features state-of-the-art automated software that provides rapid, effortless, precise, and in-depth insights about a sample's thermodynamic properties.
The TA Instruments RS-DSC is now available globally to all customers through the TA Instruments Division of Waters Corporation.
Additional Resources
About Waters Corporation ( www.waters.com )
Waters Corporation (NYSE: WAT ), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 7,700 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.

Frequently Asked Questions

What is the TA Instruments RS-DSC designed for?

It is designed for biopharmaceutical developers to test thermal stability.

How does the RS-DSC improve drug stability testing?

It offers high-throughput and accurate assessments for biologic formulations.

What technology does the RS-DSC utilize?

It uses disposable microfluidic chips for simultaneous measurements.

What advantages does the RS-DSC provide over other methods?

It reduces sample dilution, lowers contamination risk, and improves accuracy.

Where can the RS-DSC be purchased?

It is available globally through the TA Instruments Division of Waters Corporation.

Last updated: Jul 23, 2024